Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor α

被引:38
|
作者
Mukherjee, R [1 ]
Sun, SX [1 ]
Santomenna, L [1 ]
Miao, B [1 ]
Walton, H [1 ]
Liao, B [1 ]
Locke, K [1 ]
Zhang, JH [1 ]
Nguyen, SH [1 ]
Zhang, LT [1 ]
Murphy, K [1 ]
Ross, HO [1 ]
Xia, MX [1 ]
Teleha, C [1 ]
Chen, SY [1 ]
Selling, B [1 ]
Wynn, R [1 ]
Burn, T [1 ]
Young, PR [1 ]
机构
[1] Bristol Myers Squibb Co, Cardiovasc Dis Res, Expt Stn, Wilmington, DE 19880 USA
关键词
peroxisome proliferator activated receptor coactivator; ligand; fluorescence resonance energy transfer;
D O I
10.1016/S0960-0760(02)00066-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism by which ligands of nuclear receptors show differential effects on gene transcription is not fully understood, but is believed to result in part from the preferential recruitment and/or displacement of coactivators and corepressors. We have explored the interaction of several known ligands and the nuclear receptor (peroxisome proliferator activated receptor alpha, PPARalpha) using scintillation proximity assay (SPA) and the interaction of LXXLL containing peptides derived from three coactivators (SRC-1 CBP and PGC-1) with PPARalpha in the presence of PPARalpha agonist ligands using fluorescence resonance energy transfer (FRET). The EC(50)s of the individual ligands for recruitment showed the same rank order regardless of the coactivator peptide used. with GW2331 < WY14643 = ciprofibrate < L165041 < gemfibrozil. Similarly, for all ligands tested, the rank order of EC50 for peptide recruitment was CBP < PGC-1 < SRC-1. These data suggest that for these LXXLL coactivator peptides, the ligands do not substantially differ in their preferences. Partial agonism was observed with ciprofibrate and PGC-1 and gemfibrozil and CB P giving a lower FRET at saturation than with the other ligands. This suggests that ciprofibrate and gemfibrozil induce a different conformation to the receptor-PGC-1 and receptor-CBP complex, respectively. In cotransfection assays, unexpected differences in potencies and efficacies were observed and the rank order of EC(50)s for activation differed from that predicted by FRET assays, In most cases. the presence of a coactivator peptide led to decrease in the EC(50)s seen in FRET assays compared to the K(i)s observed in binding to receptor only, consistent with the lower EC(50)s obtained in the transfection assays. Our data demonstrate that ligand induced coactivator preferences of PPARalpha contribute to transcription potency and efficacy. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 50 条
  • [31] Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α in the Spotlight with Multiple Sclerosis
    Yang, Ya-Na
    Zhang, Mao-Qing
    Yu, Feng-Lin
    Bao, Ming-Yue
    Li, Xing
    Zhang, Yuan
    NEUROSCIENCE BULLETIN, 2024, 40 (02) : 268 - 272
  • [32] The role of peroxisome proliferator-activated receptor-coactivator-1 gene in skin aging
    Aghaei, Shahrzad
    Nilforoushzadeh, Mohammad Ali
    Aghaei, Maryam
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2016, 21
  • [33] An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle
    Handschin, C
    Rhee, J
    Lin, JD
    Tarr, PT
    Spiegelman, BM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) : 7111 - 7116
  • [34] Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor α and Peroxisome Proliferator-Activated Receptor γ Coactivator 1α-Dependent Gene Expression to Increase Blood Triglyceride Levels
    Shizu, Ryota
    Otsuka, Yuta
    Ezaki, Kanako
    Ishii, Chizuru
    Arakawa, Shingo
    Amaike, Yuto
    Abe, Taiki
    Hosaka, Takuomi
    Sasaki, Takamitsu
    Kanno, Yuichiro
    Miyata, Masaaki
    Yamazoe, Yasushi
    Yoshinari, Kouichi
    MOLECULAR PHARMACOLOGY, 2020, 98 (05) : 634 - 647
  • [35] Ligand activation of peroxisome proliferator-activated receptor β inhibits colon carcinogenesis
    Marin, HE
    Peraza, MA
    Billin, AN
    Willson, TM
    Ward, JM
    Kennett, MJ
    Gonzalez, FJ
    Peters, JM
    CANCER RESEARCH, 2006, 66 (08) : 4394 - 4401
  • [36] Peroxisome proliferator activated receptor γ and oxidized docosahexaenoic acids as new class of ligand
    Toshimasa Itoh
    Keiko Yamamoto
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 377 : 541 - 547
  • [37] Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-α
    Lee, Ji Hae
    Jun, Hee-jin
    Hoang, Minh-Hien
    Jia, Yaoyao
    Han, Xiang Hua
    Lee, Dong-Ho
    Lee, Hak-Ju
    Hwang, Bang Yeon
    Lee, Sung-Joon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (04) : 568 - 572
  • [38] Peroxisome proliferator activated receptor γ and oxidized docosahexaenoic acids as new class of ligand
    Itoh, Toshimasa
    Yamamoto, Keiko
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 (4-6) : 541 - 547
  • [39] Flexible ligand recognition of peroxisome proliferator-activated receptor-γ (PPARγ)
    Yamagishi, Kenji
    Yamamoto, Keiko
    Mochizuki, Yuji
    Nakano, Tatsuya
    Yamada, Sachiko
    Tokiwa, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (11) : 3344 - 3347
  • [40] Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-γ ligand
    Sarayba, MA
    Li, L
    Tungsiripat, T
    Liu, NH
    Sweet, PM
    Patel, AJ
    Osann, KE
    Chittiboyina, A
    Benson, SC
    Pershadsingh, HA
    Chuck, RS
    EXPERIMENTAL EYE RESEARCH, 2005, 80 (03) : 435 - 442